{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T17:08:01Z","timestamp":1773076081700,"version":"3.50.1"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"DOI":"10.1007\/s10741-024-10463-1","type":"journal-article","created":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T09:03:00Z","timestamp":1730970180000},"page":"293-314","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The road to renal denervation for hypertension and beyond (HF): two decades of failed, succeeded, and to be determined"],"prefix":"10.1007","volume":"30","author":[{"given":"Haoran","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veraprapas","family":"Kittipibul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Mahfoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"B\u00f6hm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul A.","family":"Sobotka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murray","family":"Esler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marat","family":"Fudim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,7]]},"reference":[{"key":"10463_CR1","doi-asserted-by":"publisher","unstructured":"Kirkland EB, Heincelman M, Bishu KG, et al (2018) Trends in healthcare expenditures among US adults with hypertension: national estimates, 2003\u20132014. J Am Heart Assoc 2018;7(11). https:\/\/doi.org\/10.1161\/JAHA.118.008731.","DOI":"10.1161\/JAHA.118.008731"},{"key":"10463_CR2","unstructured":"Ostchega Y, Fryar CD, Nwankwo T, Nguyen DT. Hypertension prevalence among adults aged 18 and over: United States, 2017\u20132018. NCHS Data Brief 2020(364):1\u20138. (https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32487290)."},{"issue":"6","key":"10463_CR3","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1161\/HYP.0000000000000066","volume":"71","author":"PK Whelton","year":"2018","unstructured":"Whelton PK, Carey RM, Aronow WS et al (2018) 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the american college of cardiology\/american heart association task force on clinical practice guidelines. Hypertension 71(6):1269\u20131324. https:\/\/doi.org\/10.1161\/HYP.0000000000000066","journal-title":"Hypertension"},{"issue":"6","key":"10463_CR4","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1161\/HYPERTENSIONAHA.111.170308","volume":"57","author":"SD Persell","year":"2011","unstructured":"Persell SD (2011) Prevalence of resistant hypertension in the United States, 2003\u20132008. Hypertension 57(6):1076\u20131080. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.111.170308","journal-title":"Hypertension"},{"issue":"5","key":"10463_CR5","doi-asserted-by":"publisher","first-page":"e53","DOI":"10.1161\/HYP.0000000000000084","volume":"72","author":"RM Carey","year":"2018","unstructured":"Carey RM, Calhoun DA, Bakris GL et al (2018) Resistant hypertension: detection, evaluation, and management: a scientific statement from the american heart association. Hypertension 72(5):e53\u2013e90. https:\/\/doi.org\/10.1161\/HYP.0000000000000084","journal-title":"Hypertension"},{"key":"10463_CR6","doi-asserted-by":"publisher","unstructured":"Fudim M, Sobotka AA, Yin YH, et al. Selective vs. global renal denervation: a case for less is more. Curr Hypertens Rep 2018;20(5):37. https:\/\/doi.org\/10.1007\/s11906-018-0838-2.","DOI":"10.1007\/s11906-018-0838-2"},{"key":"10463_CR7","doi-asserted-by":"publisher","unstructured":"Barbato E, Azizi M, Schmieder RE, et al. Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI). EuroIntervention 2023;18(15):1227\u20131243. https:\/\/doi.org\/10.4244\/EIJ-D-22-00723.","DOI":"10.4244\/EIJ-D-22-00723"},{"issue":"1","key":"10463_CR8","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1152\/physrev.1997.77.1.75","volume":"77","author":"GF DiBona","year":"1997","unstructured":"DiBona GF, Kopp UC (1997) Neural control of renal function. Physiol Rev 77(1):75\u2013197. https:\/\/doi.org\/10.1152\/physrev.1997.77.1.75","journal-title":"Physiol Rev"},{"issue":"5","key":"10463_CR9","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1002\/ca.21280","volume":"25","author":"DS Atherton","year":"2012","unstructured":"Atherton DS, Deep NL, Mendelsohn FO (2012) Micro-anatomy of the renal sympathetic nervous system: a human postmortem histologic study. Clin Anat 25(5):628\u2013633. https:\/\/doi.org\/10.1002\/ca.21280","journal-title":"Clin Anat"},{"key":"10463_CR10","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3389\/fmed.2018.00082","volume":"5","author":"Y Sata","year":"2018","unstructured":"Sata Y, Head GA, Denton K, May CN, Schlaich MP (2018) Role of the sympathetic nervous system and its modulation in renal hypertension. Front Med (Lausanne) 5:82. https:\/\/doi.org\/10.3389\/fmed.2018.00082","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"10463_CR11","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/cphy.c150047","volume":"7","author":"JW Osborn","year":"2017","unstructured":"Osborn JW, Foss JD (2017) Renal nerves and long-term control of arterial pressure. Compr Physiol 7(2):263\u2013320. https:\/\/doi.org\/10.1002\/cphy.c150047","journal-title":"Compr Physiol"},{"key":"10463_CR12","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1146\/annurev-physiol-031620-091656","volume":"83","author":"JW Osborn","year":"2021","unstructured":"Osborn JW, Tyshynsky R, Vulchanova L (2021) Function of renal nerves in kidney physiology and pathophysiology. Annu Rev Physiol 83:429\u2013450. https:\/\/doi.org\/10.1146\/annurev-physiol-031620-091656","journal-title":"Annu Rev Physiol"},{"issue":"1","key":"10463_CR13","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1161\/01.cir.5.1.91","volume":"5","author":"JM Moyer","year":"1952","unstructured":"Moyer JM, Handley CA (1952) Norepinephrine and epinephrine effect on renal hemodynamics, with particular reference to the possibility of vascular shunting and decreasing the active glomeruli. Circulation 5(1):91\u201397. https:\/\/doi.org\/10.1161\/01.cir.5.1.91","journal-title":"Circulation"},{"issue":"6","key":"10463_CR14","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1161\/01.res.29.6.646","volume":"29","author":"JA Johnson","year":"1971","unstructured":"Johnson JA, Davis JO, Witty RT (1971) Effects of catecholamines and renal nerve stimulation on renin release in the nonfiltering kidney. Circ Res 29(6):646\u2013653. https:\/\/doi.org\/10.1161\/01.res.29.6.646","journal-title":"Circ Res"},{"key":"10463_CR15","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1113\/jphysiol.1984.sp015308","volume":"352","author":"IF Hesse","year":"1984","unstructured":"Hesse IF, Johns EJ (1984) The subtype of alpha-adrenoceptor involved in the neural control of renal tubular sodium reabsorption in the rabbit. J Physiol 352:527\u2013538. https:\/\/doi.org\/10.1113\/jphysiol.1984.sp015308","journal-title":"J Physiol"},{"key":"10463_CR16","doi-asserted-by":"publisher","unstructured":"Edlund A, Sollevi A. Renal effects of i.v. adenosine infusion in humans. Clin Physiol 1993;13(4):361\u201371. https:\/\/doi.org\/10.1111\/j.1475-097x.1993.tb00336.x.","DOI":"10.1111\/j.1475-097x.1993.tb00336.x"},{"issue":"2","key":"10463_CR17","doi-asserted-by":"publisher","first-page":"196","DOI":"10.5527\/wjn.v4.i2.196","volume":"4","author":"MR Choi","year":"2015","unstructured":"Choi MR, Kouyoumdzian NM, Rukavina Mikusic NL et al (2015) Renal dopaminergic system: pathophysiological implications and clinical perspectives. World J Nephrol 4(2):196\u2013212. https:\/\/doi.org\/10.5527\/wjn.v4.i2.196","journal-title":"World J Nephrol"},{"issue":"3","key":"10463_CR18","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/0165-1838(83)90112-1","volume":"8","author":"JE Norvell","year":"1983","unstructured":"Norvell JE, Anderson JM (1983) Assessment of possible parasympathetic innervation of the kidney. J Auton Nerv Syst 8(3):291\u2013294. https:\/\/doi.org\/10.1016\/0165-1838(83)90112-1","journal-title":"J Auton Nerv Syst"},{"issue":"2 Pt 2","key":"10463_CR19","doi-asserted-by":"publisher","first-page":"F189","DOI":"10.1152\/ajprenal.1986.250.2.F189","volume":"250","author":"VH Gattone 2nd","year":"1986","unstructured":"Gattone VH 2nd, Marfurt CF, Dallie S (1986) Extrinsic innervation of the rat kidney: a retrograde tracing study. Am J Physiol 250(2 Pt 2):F189\u2013F196. https:\/\/doi.org\/10.1152\/ajprenal.1986.250.2.F189","journal-title":"Am J Physiol"},{"issue":"2","key":"10463_CR20","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/s0022-5320(75)80141-9","volume":"53","author":"L Barajas","year":"1975","unstructured":"Barajas L, Wang P (1975) Demonstration of acetylcholinesterase in the adrenergic nerves of the renal glomerular arterioles. J Ultrastruct Res 53(2):244\u2013253. https:\/\/doi.org\/10.1016\/s0022-5320(75)80141-9","journal-title":"J Ultrastruct Res"},{"key":"10463_CR21","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.aanat.2015.11.004","volume":"204","author":"WA van Amsterdam","year":"2016","unstructured":"van Amsterdam WA, Blankestijn PJ, Goldschmeding R, Bleys RL (2016) The morphological substrate for renal denervation: nerve distribution patterns and parasympathetic nerves. A post-mortem histological study Ann Anat 204:71\u201379. https:\/\/doi.org\/10.1016\/j.aanat.2015.11.004","journal-title":"A post-mortem histological study Ann Anat"},{"issue":"12","key":"10463_CR22","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1681\/ASN.2021111518","volume":"33","author":"X Cheng","year":"2022","unstructured":"Cheng X, Zhang Y, Chen R et al (2022) Anatomical evidence for parasympathetic innervation of the renal vasculature and pelvis. J Am Soc Nephrol 33(12):2194\u20132210. https:\/\/doi.org\/10.1681\/ASN.2021111518","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10463_CR23","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12967-023-03919-9","volume":"21","author":"H Liu","year":"2023","unstructured":"Liu H, Li Y, Zhou H et al (2023) Renal nerve stimulation identifies renal innervation and optimizes the strategy for renal denervation in canine. J Transl Med 21(1):100. https:\/\/doi.org\/10.1186\/s12967-023-03919-9","journal-title":"J Transl Med"},{"key":"10463_CR24","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.ijcard.2015.04.196","volume":"190","author":"H Murai","year":"2015","unstructured":"Murai H, Okuyama Y, Sakata Y et al (2015) Different responses of arterial blood pressure to electrical stimulation of the renal artery in patients with resistant hypertension. Int J Cardiol 190:296\u2013298. https:\/\/doi.org\/10.1016\/j.ijcard.2015.04.196","journal-title":"Int J Cardiol"},{"issue":"1","key":"10463_CR25","doi-asserted-by":"publisher","first-page":"R279","DOI":"10.1152\/ajpregu.2001.281.1.R279","volume":"281","author":"UC Kopp","year":"2001","unstructured":"Kopp UC, Cicha MZ, Smith LA, Hokfelt T (2001) Nitric oxide modulates renal sensory nerve fibers by mechanisms related to substance P receptor activation. Am J Physiol Regul Integr Comp Physiol 281(1):R279\u2013R290. https:\/\/doi.org\/10.1152\/ajpregu.2001.281.1.R279","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"5","key":"10463_CR26","doi-asserted-by":"publisher","first-page":"F1427","DOI":"10.1152\/ajprenal.90599.2008","volume":"297","author":"T Ditting","year":"2009","unstructured":"Ditting T, Tiegs G, Rodionova K et al (2009) Do distinct populations of dorsal root ganglion neurons account for the sensory peptidergic innervation of the kidney? Am J Physiol Renal Physiol 297(5):F1427\u2013F1434. https:\/\/doi.org\/10.1152\/ajprenal.90599.2008","journal-title":"Am J Physiol Renal Physiol"},{"issue":"2","key":"10463_CR27","doi-asserted-by":"publisher","first-page":"R79","DOI":"10.1152\/ajpregu.00351.2014","volume":"308","author":"UC Kopp","year":"2015","unstructured":"Kopp UC (2015) Role of renal sensory nerves in physiological and pathophysiological conditions. Am J Physiol Regul Integr Comp Physiol 308(2):R79-95. https:\/\/doi.org\/10.1152\/ajpregu.00351.2014","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10463_CR28","doi-asserted-by":"publisher","unstructured":"Lee S, Malykhina AP. Neuro-tracing approach to study kidney innervation: a technical note. Kidney Res Clin Pract 2017;36(1):86\u201394. https:\/\/doi.org\/10.23876\/j.krcp.2017.36.1.86.","DOI":"10.23876\/j.krcp.2017.36.1.86"},{"issue":"1\u20132","key":"10463_CR29","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/0006-8993(87)91598-8","volume":"435","author":"MM Knuepfer","year":"1987","unstructured":"Knuepfer MM, Schramm LP (1987) The conduction velocities and spinal projections of single renal afferent fibers in the rat. Brain Res 435(1\u20132):167\u2013173. https:\/\/doi.org\/10.1016\/0006-8993(87)91598-8","journal-title":"Brain Res"},{"key":"10463_CR30","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.autneu.2016.08.008","volume":"204","author":"H Zheng","year":"2017","unstructured":"Zheng H, Patel KP (2017) Integration of renal sensory afferents at the level of the paraventricular nucleus dictating sympathetic outflow. Auton Neurosci 204:57\u201364. https:\/\/doi.org\/10.1016\/j.autneu.2016.08.008","journal-title":"Auton Neurosci"},{"issue":"1","key":"10463_CR31","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s41392-023-01402-x","volume":"8","author":"W Cao","year":"2023","unstructured":"Cao W, Yang Z, Liu X et al (2023) A kidney-brain neural circuit drives progressive kidney damage and heart failure. Signal Transduct Target Ther 8(1):184. https:\/\/doi.org\/10.1038\/s41392-023-01402-x","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"10463_CR32","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/0006-8993(84)90941-7","volume":"290","author":"OR Simon","year":"1984","unstructured":"Simon OR, Schramm LP (1984) The spinal course and medullary termination of myelinated renal afferents in the rat. Brain Res 290(2):239\u2013247. https:\/\/doi.org\/10.1016\/0006-8993(84)90941-7","journal-title":"Brain Res"},{"issue":"4","key":"10463_CR33","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1161\/01.res.43.4.534","volume":"43","author":"GM Recordati","year":"1978","unstructured":"Recordati GM, Moss NG, Waselkov L (1978) Renal chemoreceptors in the rat. Circ Res 43(4):534\u2013543. https:\/\/doi.org\/10.1161\/01.res.43.4.534","journal-title":"Circ Res"},{"issue":"2","key":"10463_CR34","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1113\/jphysiol.1971.sp009673","volume":"219","author":"A Nijima","year":"1971","unstructured":"Nijima A (1971) Afferent discharges from arterial mechanoreceptors in the kidney of the rabbit. J Physiol 219(2):477\u2013485. https:\/\/doi.org\/10.1113\/jphysiol.1971.sp009673","journal-title":"J Physiol"},{"issue":"4","key":"10463_CR35","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/s0306-4522(96)00441-1","volume":"76","author":"F Zheng","year":"1997","unstructured":"Zheng F, Lawson SN (1997) Neurokinin A in rat renal afferent neurons and in nerve fibres within smooth muscle and epithelium of rat and guinea-pig renal pelvis. Neuroscience 76(4):1245\u20131255. https:\/\/doi.org\/10.1016\/s0306-4522(96)00441-1","journal-title":"Neuroscience"},{"issue":"2\u20134","key":"10463_CR36","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/0165-1838(81)90066-7","volume":"3","author":"G Recordati","year":"1981","unstructured":"Recordati G, Moss NG, Genovesi S, Rogenes P (1981) Renal chemoreceptors. J Auton Nerv Syst 3(2\u20134):237\u2013251. https:\/\/doi.org\/10.1016\/0165-1838(81)90066-7","journal-title":"J Auton Nerv Syst"},{"issue":"6","key":"10463_CR37","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1139\/y94-090","volume":"72","author":"N Ashton","year":"1994","unstructured":"Ashton N, Clarke CG, Eddy DE, Swift FV (1994) Mechanisms involved in the activation of ischemically sensitive, afferent renal nerve mediated reflex increases in hind-limb vascular resistance in the anesthetized rabbit. Can J Physiol Pharmacol 72(6):637\u2013643. https:\/\/doi.org\/10.1139\/y94-090","journal-title":"Can J Physiol Pharmacol"},{"key":"10463_CR38","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1152\/ajplegacy.1945.145.1.38","volume":"145","author":"FJ Kottke","year":"1945","unstructured":"Kottke FJ, Kubicek WG, Visscher MB (1945) The production of arterial hypertension by chronic renal artery-nerve stimulation. Am J Physiol 145:38\u201347. https:\/\/doi.org\/10.1152\/ajplegacy.1945.145.1.38","journal-title":"Am J Physiol"},{"issue":"16","key":"10463_CR39","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1001\/jama.1953.03690160001001","volume":"152","author":"RH Smithwick","year":"1953","unstructured":"Smithwick RH, Thompson JE (1953) Splanchnicectomy for essential hypertension; results in 1,266 cases. J Am Med Assoc 152(16):1501\u20131504. https:\/\/doi.org\/10.1001\/jama.1953.03690160001001","journal-title":"J Am Med Assoc"},{"issue":"1","key":"10463_CR40","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1161\/01.hyp.11.1.3","volume":"11","author":"M Esler","year":"1988","unstructured":"Esler M, Jennings G, Korner P et al (1988) Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover. Hypertension 11(1):3\u201320. https:\/\/doi.org\/10.1161\/01.hyp.11.1.3","journal-title":"Hypertension"},{"key":"10463_CR41","unstructured":"Levin HR, Gelfand M. Renal nerve stimulation method for treatment of patients. Ardian Inc; 2007."},{"issue":"4","key":"10463_CR42","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/s41440-022-01133-6","volume":"46","author":"W Roubsanthisuk","year":"2023","unstructured":"Roubsanthisuk W, Kunanon S, Chattranukulchai P et al (2023) 2022 Renal denervation therapy for the treatment of hypertension: a statement from the thai hypertension society. Hypertens Res 46(4):898\u2013912. https:\/\/doi.org\/10.1038\/s41440-022-01133-6","journal-title":"Hypertens Res"},{"issue":"2","key":"10463_CR43","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2174\/1573402115666190301154100","volume":"16","author":"AL Wilson","year":"2020","unstructured":"Wilson AL, Gandhi J, Suh Y, Joshi G, Smith NL, Khan SA (2020) Renal innervation in resistant hypertension: a review of pathophysiology and renal denervation as potential treatment. Curr Hypertens Rev 16(2):115\u2013127. https:\/\/doi.org\/10.2174\/1573402115666190301154100","journal-title":"Curr Hypertens Rev"},{"issue":"12","key":"10463_CR44","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1007\/s00392-011-0335-y","volume":"100","author":"PA Sobotka","year":"2011","unstructured":"Sobotka PA, Mahfoud F, Schlaich MP, Hoppe UC, Bohm M, Krum H (2011) Sympatho-renal axis in chronic disease. Clin Res Cardiol 100(12):1049\u20131057. https:\/\/doi.org\/10.1007\/s00392-011-0335-y","journal-title":"Clin Res Cardiol"},{"issue":"3","key":"10463_CR45","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/BF02002815","volume":"33","author":"JF Liard","year":"1977","unstructured":"Liard JF (1977) Renal denervation delays blood pressure increase in the spontaneously hypertensive rat. Experientia 33(3):339\u2013340. https:\/\/doi.org\/10.1007\/BF02002815","journal-title":"Experientia"},{"issue":"5","key":"10463_CR46","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1139\/y78-128","volume":"56","author":"RL Kline","year":"1978","unstructured":"Kline RL, Kelton PM, Mercer PF (1978) Effect of renal denervation on the development of hypertension in spontaneously hypertensive rats. Can J Physiol Pharmacol 56(5):818\u2013822. https:\/\/doi.org\/10.1139\/y78-128","journal-title":"Can J Physiol Pharmacol"},{"issue":"1 Pt 2","key":"10463_CR47","doi-asserted-by":"publisher","first-page":"H82","DOI":"10.1152\/ajpheart.1986.250.1.H82","volume":"250","author":"JM Wyss","year":"1986","unstructured":"Wyss JM, Aboukarsh N, Oparil S (1986) Sensory denervation of the kidney attenuates renovascular hypertension in the rat. Am J Physiol 250(1 Pt 2):H82\u2013H86. https:\/\/doi.org\/10.1152\/ajpheart.1986.250.1.H82","journal-title":"Am J Physiol"},{"issue":"6","key":"10463_CR48","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1161\/HYPERTENSIONAHA.116.07850","volume":"68","author":"CT Banek","year":"2016","unstructured":"Banek CT, Knuepfer MM, Foss JD et al (2016) Resting afferent renal nerve discharge and renal inflammation: elucidating the role of afferent and efferent renal nerves in deoxycorticosterone acetate salt hypertension. Hypertension 68(6):1415\u20131423. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.116.07850","journal-title":"Hypertension"},{"issue":"3","key":"10463_CR49","doi-asserted-by":"publisher","first-page":"R262","DOI":"10.1152\/ajpregu.00408.2015","volume":"310","author":"JD Foss","year":"2016","unstructured":"Foss JD, Fink GD, Osborn JW (2016) Differential role of afferent and efferent renal nerves in the maintenance of early- and late-phase Dahl S hypertension. Am J Physiol Regul Integr Comp Physiol 310(3):R262\u2013R267. https:\/\/doi.org\/10.1152\/ajpregu.00408.2015","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"4","key":"10463_CR50","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1097\/00000658-194111440-00018","volume":"114","author":"KS Grimson","year":"1941","unstructured":"Grimson KS (1941) Total thoracic and partial to total lumbar sympathectomy and celiac ganglionectomy in the treatment of hypertension. Ann Surg 114(4):753\u2013775. https:\/\/doi.org\/10.1097\/00000658-194111440-00018","journal-title":"Ann Surg"},{"issue":"4120","key":"10463_CR51","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1136\/bmj.2.4120.1215","volume":"2","author":"WM Craig","year":"1939","unstructured":"Craig WM (1939) Surgical treatment of hypertension. Br Med J 2(4120):1215\u20131219. https:\/\/doi.org\/10.1136\/bmj.2.4120.1215","journal-title":"Br Med J"},{"key":"10463_CR52","doi-asserted-by":"crossref","unstructured":"Grimson KS, Orgain ES, Anderson B, Broome RA, Longino FH. Results of treatment of patients with hypertension by total thoracic and partial to total lumbar sympathectomy, splanchnicectomy and celiac ganglionectomy. Ann Surg 1949;129(6):850\u201371. (https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17859363).","DOI":"10.1097\/00000658-194906000-00012"},{"key":"10463_CR53","doi-asserted-by":"publisher","unstructured":"Mountfort K, Mahfoud F, Schmieder R, et al. Catheter-based renal sympathetic denervation - long-term symplicity renal denervation clinical evidence, new data and future perspectives. Interv Cardiol 2013;8(2):118\u2013123. https:\/\/doi.org\/10.15420\/icr.2013.8.2.118.","DOI":"10.15420\/icr.2013.8.2.118"},{"issue":"6","key":"10463_CR54","doi-asserted-by":"publisher","first-page":"931","DOI":"10.2217\/fca-2020-0228","volume":"17","author":"Y Sato","year":"2021","unstructured":"Sato Y, Kawakami R, Sakamoto A et al (2021) Paradise ultrasound renal denervation system for the treatment of hypertension. Future Cardiol 17(6):931\u2013944. https:\/\/doi.org\/10.2217\/fca-2020-0228","journal-title":"Future Cardiol"},{"issue":"6","key":"10463_CR55","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jcin.2015.11.041","volume":"9","author":"TA Fischell","year":"2016","unstructured":"Fischell TA, Ebner A, Gallo S et al (2016) Transcatheter alcohol-mediated perivascular renal denervation with the peregrine system: first-in-human experience. JACC Cardiovasc Interv 9(6):589\u2013598. https:\/\/doi.org\/10.1016\/j.jcin.2015.11.041","journal-title":"JACC Cardiovasc Interv"},{"issue":"9917","key":"10463_CR56","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/S0140-6736(13)62192-3","volume":"383","author":"H Krum","year":"2014","unstructured":"Krum H, Schlaich MP, Sobotka PA et al (2014) Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the symplicity HTN-1 study. Lancet 383(9917):622\u2013629. https:\/\/doi.org\/10.1016\/S0140-6736(13)62192-3","journal-title":"Lancet"},{"issue":"26","key":"10463_CR57","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1093\/eurheartj\/ehu209","volume":"35","author":"MD Esler","year":"2014","unstructured":"Esler MD, Bohm M, Sievert H et al (2014) Catheter-based renal denervation for treatment of patients with treatment-resistant hypertension: 36 month results from the symplicity htn-2 randomized clinical trial. Eur Heart J 35(26):1752\u20131759. https:\/\/doi.org\/10.1093\/eurheartj\/ehu209","journal-title":"Eur Heart J"},{"issue":"42","key":"10463_CR58","doi-asserted-by":"publisher","first-page":"3474","DOI":"10.1093\/eurheartj\/ehz118","volume":"40","author":"F Mahfoud","year":"2019","unstructured":"Mahfoud F, Bohm M, Schmieder R et al (2019) Effects of renal denervation on kidney function and long-term outcomes: 3-year follow-up from the global symplicity registry. Eur Heart J 40(42):3474\u20133482. https:\/\/doi.org\/10.1093\/eurheartj\/ehz118","journal-title":"Eur Heart J"},{"issue":"9671","key":"10463_CR59","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/S0140-6736(09)60566-3","volume":"373","author":"H Krum","year":"2009","unstructured":"Krum H, Schlaich M, Whitbourn R et al (2009) Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 373(9671):1275\u20131281. https:\/\/doi.org\/10.1016\/S0140-6736(09)60566-3","journal-title":"Lancet"},{"issue":"9756","key":"10463_CR60","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1016\/S0140-6736(10)62039-9","volume":"376","author":"HTNI Symplicity","year":"2010","unstructured":"Symplicity HTNI, Esler MD, Krum H et al (2010) Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 376(9756):1903\u20131909. https:\/\/doi.org\/10.1016\/S0140-6736(10)62039-9","journal-title":"Lancet"},{"issue":"15","key":"10463_CR61","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1056\/NEJMoa1402670","volume":"370","author":"DL Bhatt","year":"2014","unstructured":"Bhatt DL, Kandzari DE, O\u2019Neill WW et al (2014) A controlled trial of renal denervation for resistant hypertension. N Engl J Med 370(15):1393\u20131401. https:\/\/doi.org\/10.1056\/NEJMoa1402670","journal-title":"N Engl J Med"},{"issue":"4","key":"10463_CR62","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1093\/eurheartj\/ehu441","volume":"36","author":"DE Kandzari","year":"2015","unstructured":"Kandzari DE, Bhatt DL, Brar S et al (2015) Predictors of blood pressure response in the SYMPLICITY HTN-3 trial. Eur Heart J 36(4):219\u2013227. https:\/\/doi.org\/10.1093\/eurheartj\/ehu441","journal-title":"Eur Heart J"},{"issue":"13","key":"10463_CR63","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1016\/j.jacc.2015.01.037","volume":"65","author":"GL Bakris","year":"2015","unstructured":"Bakris GL, Townsend RR, Flack JM et al (2015) 12-month blood pressure results of catheter-based renal artery denervation for resistant hypertension: the SYMPLICITY HTN-3 trial. J Am Coll Cardiol 65(13):1314\u20131321. https:\/\/doi.org\/10.1016\/j.jacc.2015.01.037","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10463_CR64","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1161\/HYPERTENSIONAHA.117.08928","volume":"71","author":"JW Osborn","year":"2018","unstructured":"Osborn JW, Banek CT (2018) Catheter-based renal nerve ablation as a novel hypertension therapy: lost, and then found, in translation. Hypertension 71(3):383\u2013388. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.117.08928","journal-title":"Hypertension"},{"issue":"10361","key":"10463_CR65","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/S0140-6736(22)01787-1","volume":"400","author":"DL Bhatt","year":"2022","unstructured":"Bhatt DL, Vaduganathan M, Kandzari DE et al (2022) Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial. Lancet 400(10361):1405\u20131416. https:\/\/doi.org\/10.1016\/S0140-6736(22)01787-1","journal-title":"Lancet"},{"issue":"9981","key":"10463_CR66","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1016\/S0140-6736(14)61942-5","volume":"385","author":"M Azizi","year":"2015","unstructured":"Azizi M, Sapoval M, Gosse P et al (2015) Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial. Lancet 385(9981):1957\u20131965. https:\/\/doi.org\/10.1016\/S0140-6736(14)61942-5","journal-title":"Lancet"},{"issue":"1","key":"10463_CR67","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ahj.2015.08.021","volume":"171","author":"DE Kandzari","year":"2016","unstructured":"Kandzari DE, Kario K, Mahfoud F et al (2016) The SPYRAL HTN Global Clinical Trial Program: rationale and design for studies of renal denervation in the absence (SPYRAL HTN OFF-MED) and presence (SPYRAL HTN ON-MED) of antihypertensive medications. Am Heart J 171(1):82\u201391. https:\/\/doi.org\/10.1016\/j.ahj.2015.08.021","journal-title":"Am Heart J"},{"issue":"10137","key":"10463_CR68","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1016\/S0140-6736(18)30951-6","volume":"391","author":"DE Kandzari","year":"2018","unstructured":"Kandzari DE, Bohm M, Mahfoud F et al (2018) Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial. Lancet 391(10137):2346\u20132355. https:\/\/doi.org\/10.1016\/S0140-6736(18)30951-6","journal-title":"Lancet"},{"issue":"19","key":"10463_CR69","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1016\/j.jacc.2023.08.045","volume":"82","author":"DE Kandzari","year":"2023","unstructured":"Kandzari DE, Townsend RR, Kario K et al (2023) Safety and efficacy of renal denervation in patients taking antihypertensive medications. J Am Coll Cardiol 82(19):1809\u20131823. https:\/\/doi.org\/10.1016\/j.jacc.2023.08.045","journal-title":"J Am Coll Cardiol"},{"issue":"10108","key":"10463_CR70","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1016\/S0140-6736(17)32281-X","volume":"390","author":"RR Townsend","year":"2017","unstructured":"Townsend RR, Mahfoud F, Kandzari DE et al (2017) Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial. Lancet 390(10108):2160\u20132170. https:\/\/doi.org\/10.1016\/S0140-6736(17)32281-X","journal-title":"Lancet"},{"issue":"10234","key":"10463_CR71","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/S0140-6736(20)30554-7","volume":"395","author":"M Bohm","year":"2020","unstructured":"Bohm M, Kario K, Kandzari DE et al (2020) Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial. Lancet 395(10234):1444\u20131451. https:\/\/doi.org\/10.1016\/S0140-6736(20)30554-7","journal-title":"Lancet"},{"issue":"10137","key":"10463_CR72","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1016\/S0140-6736(18)31082-1","volume":"391","author":"M Azizi","year":"2018","unstructured":"Azizi M, Schmieder RE, Mahfoud F et al (2018) Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial. Lancet 391(10137):2335\u20132345. https:\/\/doi.org\/10.1016\/S0140-6736(18)31082-1","journal-title":"Lancet"},{"issue":"8","key":"10463_CR73","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1001\/jama.2023.0713","volume":"329","author":"M Azizi","year":"2023","unstructured":"Azizi M, Saxena M, Wang Y et al (2023) Endovascular ultrasound renal denervation to treat hypertension: the RADIANCE II randomized clinical trial. JAMA 329(8):651\u2013661. https:\/\/doi.org\/10.1001\/jama.2023.0713","journal-title":"JAMA"},{"issue":"10293","key":"10463_CR74","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1016\/S0140-6736(21)00788-1","volume":"397","author":"M Azizi","year":"2021","unstructured":"Azizi M, Sanghvi K, Saxena M et al (2021) Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial. Lancet 397(10293):2476\u20132486. https:\/\/doi.org\/10.1016\/S0140-6736(21)00788-1","journal-title":"Lancet"},{"issue":"2","key":"10463_CR75","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/s41440-021-00754-7","volume":"45","author":"K Kario","year":"2022","unstructured":"Kario K, Yokoi Y, Okamura K et al (2022) Catheter-based ultrasound renal denervation in patients with resistant hypertension: the randomized, controlled REQUIRE trial. Hypertens Res 45(2):221\u2013231. https:\/\/doi.org\/10.1038\/s41440-021-00754-7","journal-title":"Hypertens Res"},{"issue":"4","key":"10463_CR76","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.jcin.2019.10.048","volume":"13","author":"F Mahfoud","year":"2020","unstructured":"Mahfoud F, Renkin J, Sievert H et al (2020) Alcohol-mediated renal denervation using the peregrine system infusion catheter for treatment of hypertension. JACC Cardiovasc Interv 13(4):471\u2013484. https:\/\/doi.org\/10.1016\/j.jcin.2019.10.048","journal-title":"JACC Cardiovasc Interv"},{"issue":"24","key":"10463_CR77","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1161\/CIRCULATIONAHA.124.069291","volume":"149","author":"DE Kandzari","year":"2024","unstructured":"Kandzari DE, Weber MA, Pathak A et al (2024) Effect of alcohol-mediated renal denervation on blood pressure in the presence of antihypertensive medications: primary results from the TARGET BP I randomized clinical trial. Circulation 149(24):1875\u20131884. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.124.069291","journal-title":"Circulation"},{"issue":"7","key":"10463_CR78","doi-asserted-by":"publisher","first-page":"602","DOI":"10.4244\/EIJ-D-23-00088","volume":"19","author":"A Pathak","year":"2023","unstructured":"Pathak A, Rudolph UM, Saxena M et al (2023) Alcohol-mediated renal denervation in patients with hypertension in the absence of antihypertensive medications. EuroIntervention 19(7):602\u2013611. https:\/\/doi.org\/10.4244\/EIJ-D-23-00088","journal-title":"EuroIntervention"},{"key":"10463_CR79","doi-asserted-by":"publisher","first-page":"102626","DOI":"10.1016\/j.eclinm.2024.102626","volume":"72","author":"J Wang","year":"2024","unstructured":"Wang J, Yin Y, Lu C et al (2024) Efficacy and safety of sympathetic mapping and ablation of renal nerves for the treatment of hypertension (SMART): 6-month follow-up of a randomised, controlled trial. EClinicalMedicine 72:102626. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102626","journal-title":"EClinicalMedicine"},{"issue":"2","key":"10463_CR80","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1161\/HYPERTENSIONAHA.114.03292","volume":"64","author":"TJ Niiranen","year":"2014","unstructured":"Niiranen TJ, Maki J, Puukka P, Karanko H, Jula AM (2014) Office, home, and ambulatory blood pressures as predictors of cardiovascular risk. Hypertension 64(2):281\u2013286. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.114.03292","journal-title":"Hypertension"},{"issue":"10","key":"10463_CR81","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1097\/HJH.0000000000003236","volume":"40","author":"ASP Sharp","year":"2022","unstructured":"Sharp ASP, Tunev S, Schlaich M et al (2022) Histological evidence supporting the durability of successful radiofrequency renal denervation in a normotensive porcine model. J Hypertens 40(10):2068\u20132075. https:\/\/doi.org\/10.1097\/HJH.0000000000003236","journal-title":"J Hypertens"},{"key":"10463_CR82","doi-asserted-by":"publisher","unstructured":"Booth LC, Nishi EE, Yao ST, et al. Reinnervation of renal afferent and efferent nerves at 5.5 and 11 months after catheter-based radiofrequency renal denervation in sheep. Hypertension 2015;65(2):393\u2013400. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.114.04176.","DOI":"10.1161\/HYPERTENSIONAHA.114.04176"},{"issue":"5","key":"10463_CR83","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.jacc.2022.11.038","volume":"81","author":"H Al Ghorani","year":"2023","unstructured":"Al Ghorani H, Kulenthiran S, Recktenwald MJM et al (2023) 10-year outcomes of catheter-based renal denervation in patients with resistant hypertension. J Am Coll Cardiol 81(5):517\u2013519. https:\/\/doi.org\/10.1016\/j.jacc.2022.11.038","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"10463_CR84","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1016\/j.jacc.2021.04.044","volume":"77","author":"F Mahfoud","year":"2021","unstructured":"Mahfoud F, Townsend RR, Kandzari DE et al (2021) Changes in plasma renin activity after renal artery sympathetic denervation. J Am Coll Cardiol 77(23):2909\u20132919. https:\/\/doi.org\/10.1016\/j.jacc.2021.04.044","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10463_CR85","doi-asserted-by":"publisher","first-page":"e008301","DOI":"10.1161\/CIRCHEARTFAILURE.121.008301","volume":"14","author":"M Fudim","year":"2021","unstructured":"Fudim M, Sobotka PA, Piccini JP, Patel MR (2021) Renal denervation for patients with heart failure: making a full circle. Circ Heart Fail 14(3):e008301. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.121.008301","journal-title":"Circ Heart Fail"},{"issue":"6","key":"10463_CR86","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1002\/ejhf.83","volume":"16","author":"M Bohm","year":"2014","unstructured":"Bohm M, Ewen S, Kindermann I, Linz D, Ukena C, Mahfoud F (2014) Renal denervation and heart failure. Eur J Heart Fail 16(6):608\u2013613. https:\/\/doi.org\/10.1002\/ejhf.83","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"10463_CR87","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ijcard.2012.09.019","volume":"162","author":"JE Davies","year":"2013","unstructured":"Davies JE, Manisty CH, Petraco R et al (2013) First-in-man safety evaluation of renal denervation for chronic systolic heart failure: primary outcome from REACH-Pilot study. Int J Cardiol 162(3):189\u2013192. https:\/\/doi.org\/10.1016\/j.ijcard.2012.09.019","journal-title":"Int J Cardiol"},{"issue":"2","key":"10463_CR88","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1007\/s12265-022-10307-z","volume":"16","author":"J Wang","year":"2023","unstructured":"Wang J, Sun N, Ge J et al (2023) Rationale and design of sympathetic mapping\/ablation of renal nerves trial (SMART) for the treatment of hypertension: a prospective, multicenter, single-blind, randomized and sham procedure-controlled study. J Cardiovasc Transl Res 16(2):358\u2013370. https:\/\/doi.org\/10.1007\/s12265-022-10307-z","journal-title":"J Cardiovasc Transl Res"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-024-10463-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-024-10463-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-024-10463-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T07:58:16Z","timestamp":1738828696000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-024-10463-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,7]]},"references-count":88,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["10463"],"URL":"https:\/\/doi.org\/10.1007\/s10741-024-10463-1","relation":{},"ISSN":["1573-7322"],"issn-type":[{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,7]]},"assertion":[{"value":"25 October 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Felix Mahfoud is supported by Deutsche Gesellschaft f\u00fcr Kardiologie, Deutsche Forschungsgemeinschaft and Deutsche Herzstiftung. He has received scientific support from Ablative Solutions, Medtronic, and ReCor Medical, and speaker honoraria\/consulting fees from Ablative Solutions, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Inari, Medtronic, Merck, ReCor Medical, Servier, and Terumo. Michael Bohm is supported by the Deutsche Forschungsgemeinschaft and reports personal fees from Abbott, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Cytokinetics, Medtronic, Novartis, Servier, and Vifor. Paul A. Sobotka consults for V\u2010Flow Medical and receives consultant honoria from SyMap Medical Ltd (Suzhou). Murray Esler is consultant and receives consultant honoraria from SyMap Medical Ltd (Suzhou). Jie Wang is a co-founder of SyMap Medical (Suzhou), LTD, has equity of the company and receives consultant honoraria from SyMap Medical (Suzhou), LTD. Marat Fudim is supported by the NIH, and Doris Duke. He received consulting fees from Abbott, Ajax, Alio Health, Alleviant, Artha, Audicor, AxonTherapies, Bayer, Bodyguide, Bodyport, Boston Scientific, Broadview, Cadence, Cardioflow, Cardionomics, Coridea, CVRx, Daxor, Deerfield Catalyst, Edwards LifeSciences, Echosens, EKO, Feldschuh Foundation, Fire1, FutureCardia, Galvani, Gradient, Hatteras, HemodynamiQ, Impulse Dynamics, Intershunt, Medtronic, Merck, NIMedical, NovoNordisk, NucleusRx, NXT Biomedical, Orchestra, Pharmacosmos, PreHealth, Presidio, Procyreon, ReCor, Rockley, SCPharma, Shifamed, Splendo, Summacor, SyMap, Verily, Vironix, Viscardia, Zoll. All other authors have no relevant financial disclosures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}